465 Shares in Axon Enterprise, Inc. (NASDAQ:AXON) Acquired by Fortis Capital Management LLC

Fortis Capital Management LLC acquired a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) in the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 465 shares of the biotechnology company’s stock, valued at approximately $276,000.

Several other institutional investors have also recently modified their holdings of AXON. PNC Financial Services Group Inc. raised its position in shares of Axon Enterprise by 17.5% during the 3rd quarter. PNC Financial Services Group Inc. now owns 5,627 shares of the biotechnology company’s stock worth $2,249,000 after purchasing an additional 840 shares during the last quarter. Jennison Associates LLC raised its position in shares of Axon Enterprise by 48.2% during the 3rd quarter. Jennison Associates LLC now owns 3,977 shares of the biotechnology company’s stock worth $1,589,000 after purchasing an additional 1,294 shares during the last quarter. King Luther Capital Management Corp raised its holdings in Axon Enterprise by 0.3% in the 3rd quarter. King Luther Capital Management Corp now owns 10,474 shares of the biotechnology company’s stock valued at $4,185,000 after acquiring an additional 34 shares during the last quarter. Massachusetts Financial Services Co. MA acquired a new position in Axon Enterprise in the 3rd quarter valued at $120,553,000. Finally, Champlain Investment Partners LLC raised its holdings in Axon Enterprise by 13.9% in the 3rd quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock valued at $272,695,000 after acquiring an additional 83,265 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Stock Up 0.3 %

Shares of Axon Enterprise stock opened at $560.00 on Friday. The company has a fifty day moving average price of $591.90 and a 200 day moving average price of $542.26. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $715.99. The stock has a market cap of $42.91 billion, a price-to-earnings ratio of 144.70, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on AXON shares. Craig Hallum downgraded Axon Enterprise from a “buy” rating to a “cautious” rating in a report on Monday, March 10th. The Goldman Sachs Group boosted their price target on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a report on Monday, January 27th. Needham & Company LLC reiterated a “buy” rating and issued a $600.00 price target on shares of Axon Enterprise in a report on Wednesday, February 26th. JMP Securities reiterated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Finally, TD Cowen started coverage on Axon Enterprise in a report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target for the company. One research analyst has rated the stock with a sell rating, two have given a hold rating and eleven have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $604.67.

Insider Buying and Selling

In related news, insider Jeffrey C. Kunins sold 1,035 shares of the company’s stock in a transaction on Monday, December 23rd. The shares were sold at an average price of $624.47, for a total transaction of $646,326.45. Following the completion of the sale, the insider now directly owns 124,243 shares of the company’s stock, valued at approximately $77,586,026.21. This represents a 0.83 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 1,792 shares of company stock valued at $1,087,843. Company insiders own 5.70% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.